Why does colorectal cancer defy the rules of the immune system? In most cancers, more regulatory T cells (Tregs) mean a worse ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor. Subscribe to our ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has developed a new class of engineered extracellular vesicles (EVs) capable of ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...

A new study from Memorial Sloan Kettering Cancer Center finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Explore how engineered extracellular vesicles can enhance antigen-specific regulatory T cells to improve immune response.